Citable filing context
EL's research view summarizes recent SEC filing context, starting with management_change from Sep 8, 2026.
| Filed | Item | Context |
|---|---|---|
| Sep 8, 2026 | management_change | Estée Lauder nominated Jean-Frédéric Dufour and Matthew E. Rubel to stand for election to its board. |
| Aug 19, 2026 | earnings | Estée Lauder reported fiscal 2026 fourth-quarter and full-year results, with net sales increasing 5% to $15.0 billion. |
| Jul 24, 2026 | management_change | Director Jennifer Hyman will retire from the Board of Directors effective November 16, 2026. |
| Aug 19, 2026 | Guidance: adjusted_constant_currency_eps | 3.06 to 3.31 |
| Aug 19, 2026 | Guidance: adjusted_effective_tax_rate | 33.00 to 34.00 |
| Aug 19, 2026 | Guidance: adjusted_eps | 3.10 to 3.35 |
| Aug 19, 2026 | business | The Estée Lauder Companies Inc. operates as a global leader in prestige beauty, manufacturing and marketing products across skin care, makeup, fragrance, and hair care. Its portfolio features major owned brands—including Estée Lauder, Clinique, M·A·C, La Mer, Jo Malone London, TOM FORD, Aveda, Le Labo, Too Faced, Dr.Jart+, and The Ordinary—as well as licensed beauty lines such as AERIN and Balmain. Distribution spans department stores, travel retail, specialty-multi retailers, freestanding stores, and direct-to-consumer digital platforms. In fiscal 2026, net sales reached $15.05 billion, distributed across the Americas ($4.46 billion), Europe/EUKEM ($3.79 billion), Asia/Pacific ($3.75 billion), and Mainland China ($3.06 billion). To rebuild profit margins and streamline operations, the company is executing its Profit Recovery and Growth Plan (PRGP). This multi-year restructuring program entails approximately 10,000 net job reductions globally and total estimated pre-tax charges of $1.75 billion ($1.43 billion incurred through fiscal 2026). Recent financial performance has been impacted by demand headwinds in Asia travel retail and mainland China, resulting in intangible asset and goodwill impairments across key acquisitions, including TOM FORD, Too Faced, and Dr.Jart+. To support ongoing transformation and working capital needs, the company maintains $3.5 billion in committed revolving credit facilities. |
| Aug 19, 2026 | mda | For fiscal 2026, net sales increased 5% (3% in constant currency) to $15.05 billion. Operating income rebounded to $780 million from an operating loss of $785 million in fiscal 2025, driving diluted EPS to $0.50 compared to a prior-year loss of $3.15, while adjusted EPS rose 66% to $2.51. Performance was anchored by Skin Care ($7.34 billion net sales) and Fragrance ($2.78 billion net sales, up 10% in constant currency), benefiting from gross margin expansion, execution of the Profit Recovery and Growth Plan (PRGP), and the non-recurrence of $1.29 billion in prior-year impairment charges on Dr.Jart+, TOM FORD, and Too Faced. Geographically, Mainland China led growth with constant currency net sales up 9% to $3.06 billion and operating income rising 92% to $373 million, recovering from fiscal 2025 travel retail headwinds and North American retail destocking. Operating results were impacted by an $84 million securities class action litigation settlement in fiscal 2026 and a $159 million talcum litigation settlement charge in fiscal 2025. The reported effective tax rate surged to 64.8%, driven by foreign valuation allowances and tax law adjustments. EL ended the period with $3.50 billion in cash and cash equivalents, though credit ratings retain negative outlooks (A-/A3) amid monitoring of global tariffs. |
Source: SEC EDGAR filing text and events; period Sep 8, 2026; filed Sep 8, 2026.
EL company research is free during early access. All you need is an account, with no card required. The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay open without one.
Continue research
Follow same-sector companies and source explainers connected to the research view.
A factual guide to SEC Form 8-K current reports and the material company events they can disclose between quarterly filings.
A factual guide to quarterly SEC Form 10-Q reports, how they differ from annual 10-K filings, and what readers can inspect first.
A factual guide to Form S-1 registration statements and the disclosures companies provide before a public offering.
A factual guide to the core 10-K sections investors use for company context: business description, risk factors, MD&A, financial statements, and segment disclosures.